Buspirone
Back to searchMolecule Structure
Scientific Name
Buspirone
Description of the Drug
Buspirone is an anxiolytic agent used for short-term treatment of generalized anxiety and second-line treatment of depression.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00490
http://www.drugbank.ca/drugs/DB00490
Brand Name(s)
Not Available
Company Owner(s)
Nesher Pharmaceuticals Usa Llc, Egis Plc, Mylan Pharmaceuticals Inc, Bristol Myers Squibb Co Pharmaceutical Research Institute, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Impax Laboratories Inc, Zydus Pharmaceuticals Usa Inc, Teva Pharmaceuticals Usa Inc, Rubicon Research Private Ltd, Fosun Pharma Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Serotonin 1a (5-HT1a) receptor | SINGLE PROTEIN | PARTIAL AGONIST | CHEMBL214 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL16398 | |||
| PharmGKB | PA448689 | |||
| Human Metabolome Database | HMDB0014633 | |||
| DrugBank | DB00490 | |||
| PubChem: Thomson Pharma | 14902734 | |||
| PubChem | 2477 | |||
| Mcule | MCULE-1919697845 | |||
| LINCS | LSM-4105 | |||
| Nikkaji | J19.752A | |||
| BindingDB | 50001859 | |||
| EPA CompTox Dashboard | DTXSID2022707 | |||
| DrugCentral | 437 | |||
| Brenda | 167768 | 145045 | 145959 | |
| ChemicalBook | CB93118899 | CB1367137 | CB73118901 | CB63118898 |
| Guide to Pharmacology | 36 | |||
| rxnorm | BUSPAR | BUSPIRONE | BUSPIRONE HYDROCHLORIDE | |
| PubChem: Drugs of the Future | 24714738 | |||
| KEGG Ligand | C06861 | |||
| ChEBI | 3223 | |||
| ZINC | ZINC000001530571 |
